Processa Pharmaceuticals, Inc. (PCSA)
2.05
-0.11
(-5.09%)
USD |
NASDAQ |
Sep 09, 09:56
Processa Pharmaceuticals Total Liabilities (Quarterly) : 2.387M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.387M |
| March 31, 2026 | 1.980M |
| December 31, 2025 | 2.236M |
| September 30, 2025 | 1.751M |
| June 30, 2025 | 2.075M |
| March 31, 2025 | 1.283M |
| December 31, 2024 | 1.533M |
| September 30, 2024 | 1.221M |
| June 30, 2024 | 1.577M |
| March 31, 2024 | 1.061M |
| December 31, 2023 | 0.7975M |
| September 30, 2023 | 0.9148M |
| June 30, 2023 | 0.9307M |
| March 31, 2023 | 2.290M |
| December 31, 2022 | 1.149M |
| September 30, 2022 | 1.364M |
| June 30, 2022 | 1.576M |
| March 31, 2022 | 1.064M |
| December 31, 2021 | 3.124M |
| September 30, 2021 | 1.817M |
| June 30, 2021 | 1.896M |
| March 31, 2021 | 2.002M |
| December 31, 2020 | 4.178M |
| September 30, 2020 | 4.062M |
| June 30, 2020 | 3.418M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.778M |
| December 31, 2019 | 3.990M |
| September 30, 2019 | 2.151M |
| June 30, 2019 | 2.804M |
| March 31, 2019 | 2.954M |
| December 31, 2018 | 3.514M |
| September 30, 2018 | 2.957M |
| June 30, 2018 | 3.131M |
| March 31, 2018 | 5.610M |
| December 31, 2017 | |
| September 30, 2017 | 0.1153M |
| June 30, 2017 | 2.493M |
| March 31, 2017 | 2.439M |
| December 31, 2016 | 2.354M |
| September 30, 2016 | 2.285M |
| June 30, 2016 | 2.214M |
| March 31, 2016 | 2.165M |
| December 31, 2015 | |
| September 30, 2015 | 2.116M |
| June 30, 2015 | 2.198M |
| March 31, 2015 | 1.841M |
| December 31, 2014 | 1.334M |
| September 30, 2014 | 2.783M |
| June 30, 2014 | 2.162M |
| March 31, 2014 | 1.878M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.070M |
| Shareholders Equity (Quarterly) | -0.3173M |
| Current Ratio | 0.8657 |
| Net Debt Paydown Yield | 0.19% |